Neeland, Ian J.
30 papers on CoChatORCID 0000-0003-2831-3618
Most cited papers
- Verified
Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: Results from a randomized clinical trial
Pandey, A., Patel, K. V., Segar, M. W., Ayers, C., Linge, J., Leinhard, O. D., Anker, S. D., Butler, J., Verma, S., Joshi, P. H., et al. (2024) · Journal of Cachexia, Sarcopenia and Muscle
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 80
- Verified
Implementation of obesity science into clinical practice: a scientific statement from the American Heart Association
Laddu, D., Neeland, I. J., Carnethon, M., Stanford, F. C., Mongraw-Chaffin, M., Barone Gibbs, B., Ndumele, C. E., Longenecker, C. T., Chung, M. L., Rao, G., et al. (2024) · Circulation
Health Policy Implementation ScienceObesity and Health Practices
Cited by 62
- Verified
Cardiometabolic Health Outcomes Associated With Discordant Visceral and Liver Fat Phenotypes: Insights From the Dallas Heart Study and UK Biobank
Tejani, S., McCoy, C., Ayers, C. R., Powell-Wiley, T. M., Després, J.-P., Linge, J., Leinhard, O. D., Petersson, M., Borga, M., & Neeland, I. J. (2022) · Mayo Clinic Proceedings
Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Disease and Adiposity
Cited by 60
- Verified
Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trial
Wojeck, B. S., Inzucchi, S. E., Neeland, I. J., Mancuso, J. P., Frederich, R., Masiukiewicz, U., Cater, N. B., McGuire, D. K., Cannon, C. P., & Yaggi, H. K. (2023) · Sleep and Breathing
Diabetes Treatment and ManagementObstructive Sleep Apnea Research
Cited by 41
- Verified
Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial
Reed, J., Dong, T., Eaton, E., Friswold, J., Porges, J., Al‐Kindi, S. G., Rajagopalan, S., & Neeland, I. J. (2024) · Diabetes, Obesity and Metabolism
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 22
- Verified
The OPTIFAST total and partial meal replacement programme reduces cardiometabolic risk in adults with obesity: Secondary and exploratory analysis of the OPTIWIN study
Ard, J. D., Neeland, I. J., Rothberg, A. E., Chilton, R. J., de Luis, D., Cohen, S. S., & Johansen, O. E. (2024) · Diabetes, Obesity and Metabolism
Diabetes, Cardiovascular Risks, and LipoproteinsBariatric Surgery and Outcomes
Cited by 12
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free